In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates

(2014) M. T. Montagna et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Diagnosis and Treatment of Invasive Fungal Infections Focus on Liposomal Amphotericin B

(2013) João F. Lacerda et al.   CLINICAL DRUG INVESTIGATION

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex

(2013) Rolin L. Wade et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis

(2012) S. Mistro et al.   CLINICAL INFECTIOUS DISEASES

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

(2012) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Interlaboratory Reproducibility of Etest Amphotericin B and Caspofungin Yeast Susceptibility Testing and Comparison with the CLSI Method

(2012) S. Ranque et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluating real-life clinical and economical burden of amphotericin-B deoxycholate adverse reactions

(2012) Ehud Horwitz et al.   International Journal of Clinical Pharmacy

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

(2010) J Maertens et al.   BONE MARROW TRANSPLANTATION

Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates

(2010) M. Cuenca-Estrella et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods

(2009) D. J. Diekema et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A multiplex PCR protocol for rapid identification of Candida glabrata and its phylogenetically related species Candida nivariensis and Candida bracarensis

(2009) Orazio Romeo et al.   JOURNAL OF MICROBIOLOGICAL METHODS

Activities of Antifungal Agents against Yeasts and Filamentous Fungi: Assessment according to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Renal impairment and Amphotericin B formulations in patients with invasive fungal infections

(2008) Faouzi Saliba et al.   MEDICAL MYCOLOGY